Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational National Clinical Trial of Safety and Tolerance in Patients Suffering of an Allergic Grass Pollen Rhinitis and Treated by Grazax in Real Life Settings

NCT01433510 is registered in ClinicalTrials.gov with ALK-Abelló A/S as lead sponsor.

NCT NCT01433510
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01433510 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational National Clinical Trial of Safety and Tolerance in Patients Suffering of an Allergic Grass Pollen Rhinitis and Treated by Grazax in Real Life Settings
Lead sponsor
ALK-Abelló A/S
Phase
Phase 4
Overall status
Completed
Start date
November 30, 2007
Completion date
December 31, 2010
Enrollment
628 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

allergic rhinoconjunctivitis